Tuberculosis control laws--United States, 1993: recommendations of the Advisory Council for the Elimination of Tuberculosis (ACET) by Centers for Disease Control and Prevention (U.S.) Advisory Council for the Elimination of Tuberculosis.
November 12, 1993 / Vol. 42 / No. RR-15
Recommendations
and
Reports
U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES
Public Health Service
Centers for Disease Control
and Prevention (CDC)
Atlanta, Georgia 30333
Tuberculosis Control Laws —
United States, 1993
Recommendations of the
Advisory Council for the Elimination
of Tuberculosis (ACET)
The MMWR series of publications is published by the Epidemiology Program Office,
Centers for Disease Control and Prevention (CDC), Public Health Service, U.S. Depart-
ment of Health and Human Services, Atlanta, Georgia 30333.
Centers for Disease Control and Prevention.............................. Walter R. Dowdle, Ph.D.
Acting Director 
The material in this report was prepared for publication by:
 Office of the Director................................................................. Walter R. Dowdle, Ph.D.
Acting Director 
  Office of the General Counsel ..............................................Gene W. Matthews, J.D.
Legal Advisor 
 National Center for Prevention Services ........................Alan R. Hinman, M.D., M.P.H.
Director 
  Division of Tuberculosis Elimination ...................................Kenneth G. Castro, M.D.
Director 
The production of this report as an MMWR serial publication was coordinated in:
 Epidemiology Program Office............................................Barbara R. Holloway, M.P.H.
Acting Director 
Richard A. Goodman, M.D., M.P.H.
Editor, MMWR Series 
  Scientific Information and Communications Program
   Recommendations and Reports................................... Suzanne M. Hewitt, M.P.A.
Managing Editor 
Rachel J. Wilson
Project Editor 
Morie M. Higgins
Visual Information Specialist 
           SUGGESTED CITATION
Centers for Disease Control and Prevention. Tuberculosis control laws—United
States,1993: recommendations of the Advisory Council for the Elimination of Tu-
berculosis (ACET). MMWR 1993;42(No. RR-15):[inclusive page numbers].
Copies can be purchased from Superintendent of Documents, U.S. Government
Printing Office, Washington, DC 20402-9325. Telephone: (202) 783-3238.
Contents
Frequently Used Terms ........................................................................................ ii
Introduction...........................................................................................................1
Methods.................................................................................................................2
Results and Recommendations...........................................................................3
 Reporting Requirements .................................................................................3
 Additional Reporting Recommendations .....................................................5
 Management of TB Cases ...............................................................................6
Conclusion...........................................................................................................11
References...........................................................................................................12
Bibliography........................................................................................................12
Appendix .............................................................................................................15
Vol. 42 / No. RR-15 MMWR i
FREQUENTLY USED TERMS
The following are the recommended definitions for key terms in tuberculosis (TB)
control laws:
Active TB. TB disease as demonstrated by clinical, bacteriologic, and/or radiographic
evidence. Persons who have not completed a course of anti-TB treatment are con-
sidered to have active TB and may be infectious.
Adherent. Taking anti-TB medications as prescribed.
Case. An occurrence of active TB.
Commitment. The confinement of a person who has infectious TB or who is noninfec-
tious, but who has not adhered to prescribed treatment. The purpose of
commitment, which occurs under judicial or administrative order, is to prevent the
transmission of tubercle bacilli to others, to prevent the development of drug-resis-
tant organisms, or to ensure that persons receive a complete course of treatment.
Contact. A person exposed to a patient who has infectious TB.
Contact investigation. Interviewing, counseling, educating, examining, and investi-
gating activities directed at persons who have been in close contact with patients
who have infectious TB.
Detention. The temporary confinement of a person who has or who is suspected of
having TB.
Directly Observed Therapy (DOT). Treatment in which health-care providers or other
designated persons observe patients ingesting anti-TB medications.
Enabler. Anything that helps the patient to more readily complete therapy (e.g., bus
fare and gasoline).
Exposure. The sharing of air with a person who has infectious tuberculosis.
Incentive. Anything that motivates the patient to adhere to treatment (e.g., food, cou-
pons, and personal items).
Infected. Having been exposed to someone with infectious tuberculosis, or having a
positive response to a tuberculin skin test, but not having clinical or radiographic
evidence of disease. Some patients who are anergic may not respond to a skin test
but still be infected. 
Infectious TB. TB disease in a communicable or infectious stage as determined by a
chest radiograph, the bacteriologic examination of body tissues or secretions, or
other diagnostic procedures.
Isolation. An infection control practice designed to prevent the transmission of tuber-
cle bacilli.
Nonadherent. Not taking medications as prescribed or not following the recommen-
dations of the attending physician or health officer for the management of TB.
Noninfectious. Not capable of transmitting tubercle bacilli. A determination of non-in-
fectiousness can be made when a patient shows significant clinical improvement
(e.g., the resolution of cough and/or fever) and has negative sputum smears on 3
consecutive days.
Quarantine. A limitation on the movement of persons exposed to, or infected with, TB
to prevent the exposure of other persons.
Suspected Case. A person with signs or symptoms of TB for whom the results of
diagnostic studies are still pending completion.
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Tuberculosis (TB). Disease caused by Mycobacterium tuberculosis  complex (i.e., M.
tuberculosis, Mycobacterium bovis, or Mycobacterium africanum).
TB Control Officer. A person appointed by the state to be responsible for the admini-
stration of state TB programs.
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Tuberculosis Control Laws — United States, 1993
Recommendations of the Advisory Council for the
Elimination of Tuberculosis (ACET)
Summary
Because of its communicable nature, tuberculosis (TB) is treated differently
than other nonairborne infectious diseases, as there are many state laws specific
to the control of TB. Many of these laws predate the current public health recom-
mendations for the prevention and control of TB. In 1989, CDC published A
Strategic Plan for the Elimination of Tuberculosis in the United States that was
developed by the Advisory Committee (now Council) for the Elimination of Tu-
berculosis (ACET) (1 ). The Plan called for the establishment of a national goal of
TB elimination (i.e., achieving a case rate of <1 per million population) by the
year 2010. One of the methods for improving disease containment in the Plan
was for the use of quarantine measures for nonadherent patients. The Plan
called for revision of state and local laws to “facilitate the cure of persons with
infectious tuberculosis,” (1 ). The issue of outdated state TB laws was also iden-
tified as a problem in the National Action Plan to Combat Multidrug-resistant
Tuberculosis (2 ).
In response to this issue, CDC conducted a survey of state TB control laws
and ACET developed recommendations to address discrepancies between pre-
viously published recommendations and guidelines for the control of TB and
state TB control laws. In order to address these discrepancies, states updating
TB control laws should incorporate current recommendations and guidelines
from CDC, ACET, and the American Thoracic Society. State laws should permit
policies and practices to be rapidly reviewed and amended as new data be-
comes available and new recommendations and guidelines are published.
INTRODUCTION
In 1989, the Advisory Committee (now Council) for the Elimination of Tuberculosis
(ACET) published A Strategic Plan for the Elimination of Tuberculosis in the United
States  (1 ). The plan promoted the goal of eliminating tuberculosis (TB) (i.e., achiev-
ing a case rate of <1 per million population) in the United States by the year 2010.
However, the plan was not fully implemented, and the number of TB cases reported in
the United States increased. From 1953 to 1984, the number of reported TB cases in
the United States declined at a rate of approximately 5% per year—from >84,000 cases
in 1953 to approximately 22,000 cases in 1984. However, from 1985 through 1992, re-
ported TB cases increased 20%. In 1992, 26,673 cases of TB were reported in the
United States—an incidence rate of 10.5 per 100,000 population. The cases from 1985
through 1992 represent an excess of >51,000 cases based on the 1980–1984 trend. The
increase in TB cases has been attributed to human immunodeficiency virus (HIV)-as-
sociated TB, immigration from countries with high TB prevalence, substance abuse,
homelessness, poverty, and a deterioration in the public health infrastructure, among
other factors.
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The increase in cases of drug-resistant TB is also of concern. From 1982 through
1986, the proportion of new cases resistant to both isoniazid and rifampin was 0.5%,
but by 1991 the proportion had increased to 3.3%. Likewise, the proportion of TB cases
among recurrent cases resistant to both drugs increased from 3.0% (1982–1986) to
7.2% (1991).
Drug resistance is prevalent in certain areas. For example, in a survey of cases in
New York City, 33% had organisms resistant to isoniazid or rifampin and 19% had or-
ganisms resistant to both drugs. Resistance to both drugs lengthens the course of
treatment from 6 months to 18–24 months, increases the cost of treatment, and de-
creases the cure rate from approximately 100% to 60%. 
Several outbreaks of multidrug-resistant TB (MDRTB) have occurred in institutional
settings. From 1990 through 1992, CDC participated in investigations of outbreaks in
hospitals and correctional facilities that involved nearly 300 cases of MDRTB. These
patients had a mortality rate of 43%–89%. To address the problem of MDRTB, in De-
cember 1991 the CDC Director convened a TB Task Force composed of representatives
of federal agencies. In 1992, the TB Task Force developed a National Action Plan to
Combat Multidrug-Resistant Tuberculosis, which details steps to be taken by federal
agencies regarding MDRTB.
Interventions listed in the National Action Plan  (e.g., the rapid reporting of con-
firmed and suspected TB cases) are addressed in state TB-control laws and
regulations. The National Action Plan  recommends that states revise their laws and
regulations to facilitate the cure of persons with infectious TB. In the fall of 1991, CDC
conducted a survey of state TB-control laws and regulations. One of the objectives of
the National Action Plan  was for ACET and CDC to develop recommendations that
address legal issues of TB controls and to publish these recommendations by 1993.
This report summarizes the results of the survey and provides recommendations to
assist states in revising their TB-control laws and regulations. These recommenda-
tions also may be applicable to county and municipal health departments. Documents
summarizing recommendations and guidelines from ACET, the American Lung Asso-
ciation (ALA), the American Thoracic Society (ATS), and CDC are provided in the
bibliography.
The goal of state TB-control programs should be to prevent, control, and eventually
eliminate TB. To protect the public from TB, these programs should ensure that per-
sons with TB receive appropriate treatment. In addition, states should develop and
encourage implementation of comprehensive programs that address the needs of
persons who have TB, including the integration of TB services with drug and alcohol
treatment programs and the expansion of public education, particularly for popula-
tions at increased risk for TB. States also should require the application of
recommended infection control measures in health-care facilities and congregate-
living settings (e.g., correctional facilities).
METHODS
TB-control officers in all states were asked to provide copies of their TB-control
laws and regulations to CDC. Certain provisions of these laws and regulations were
examined: TB reporting requirements (i.e., the persons required to report cases of TB,
the time frame for reporting, penalties for failure to report, and the duty to report
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patients who do not adhere to prescribed treatment), the restriction of some persons
from activities or employment, the screening of certain populations, contact investiga-
tion, procedures for control and treatment, penalties for patients who do not adhere to
prescribed treatment, the provision of treatment facilities, and the financing of treat-
ment (Appendix). After the laws and regulations were examined, the TB-control
officers reviewed the findings for their respective states to clarify any discrepancies. A
draft of the survey and recommendations was made available for public comment
from October 2 through November 16, 1992. Public comments were solicited through
a notice published in the Morbidity and Mortality Weekly Report  (3 ). A total of 48
persons representing private organizations and state, county, and local health depart-
ments provided comments about the draft.
RESULTS AND RECOMMENDATIONS
Reporting Requirements
Persons Required to Report Cases of TB
All states require designated health-care professionals to report cases of TB to local
or state health departments. Physicians are most frequently required to report cases
of TB (42 states). Others required to report test results or cases are laboratory direc-
tors (33 states), hospitals and hospital administrators (31 states), other health-care
workers (23 states), school authorities (22 states), nursing home administrators
(15 states), and hospital infection control officers (six states). Eight states also require
parents and guardians to report cases of TB among household members. Cases are
reported by all states to CDC using the Report of Verified Case of Tuberculosis  (CDC
Form 72.9).
Recommendation
• States should require health-care providers and allied professionals who di-
agnose TB or treat or otherwise care for TB patients to report confirmed or
suspected cases to the appropriate health agency. Among these providers
and professionals are physicians, pharmacists, nurses, infection control
officers, medical examiners, morticians, and the administrators of laborato-
ries or other facilities where TB patients receive health-care services.
Appropriate systems should be developed that maximize the reporting of
new cases and minimize the reporting of duplicate cases and suspected
cases and that protect the confidentiality of reports.
Time Frame for Reporting
State laws regarding the time allowed for reporting cases of TB vary from reporting
at the time of diagnosis to within 1 week of diagnosis. Thirteen states require report-
ing at the time of diagnosis, 14 states within 24 hours of diagnosis, seven states within
48 hours, three states within 72 hours, and six states within 1 week. Six states do not
specify a time frame for reporting.
In nine states, the time frame for reporting cases of TB depends on the reporting
source. For example, physicians may be required to report cases of TB within 7 days
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of diagnosis, whereas institutions in the same state are required to report cases within
48 hours. Reporting requirements for laboratory directors vary from reporting at the
time of identification of Mycobacterium tuberculosis  to reporting results once a week.
Recommendations
• Confirmed and suspected cases should be reported within 2 working days of
identification of M. tuberculosis  to the health agency with primary responsibility
for TB control in that jurisdiction. Reporting should be based on a diagnosis or a
presumptive diagnosis. Local health departments should report confirmed and
suspected cases to the state TB-control agency within 1 working day of notifica-
tion.
• When a case of TB is identified as being drug resistant, the case should be re-
ported again within 2 working days in a manner consistent with the reporting of
confirmed and suspected cases of TB. The report of drug-resistant TB also should
include the results of susceptibility tests.
• All bacteriologic and pathologic laboratories that perform diagnostic services or
perform related drug-susceptibility tests for M. tuberculosis  should be required
to report the results for any person whose sputa, gastric contents, or other speci-
mens submitted for examination reveal the presence of tubercle bacilli. These
results should be reported to the local health department within 1 working day of
identification.
• Laboratories that perform diagnostic services on specimens from other states
should be required to report the results to the state health department TB pro-
gram from which the specimen was received. Reports should include the
patient’s name, address, and physician, and the person or agency referring the
positive specimen for laboratory evaluation.
Failure to Report Cases of TB
Twenty-nine states have statutory authority to impose a penalty on persons who
are required to report TB cases but fail to do so. Five states impose a penalty only
when the failure to report a case is willful. Those persons found guilty of failing to
report cases may be convicted of a misdemeanor and fined from $5 to $500.
Recommendation
• Because the rapid and accurate reporting of TB cases is critical to the manage-
ment of TB patients, states should have the authority to impose a penalty for the
willful failure to report confirmed and suspected cases of TB within the required
time frame. In addition to imposing a penalty, states may refer reporting viola-
tions to professional licensing boards or, in the instance of a laboratory, to the
licensing agency.
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Duty to Report Nonadherent* Patients
Eleven states require health-care providers to report nonadherent patients. Two
states also require the attending physician to notify the state health department when
a patient has completed treatment for TB.
Recommendations
• TB patients who have demonstrated an inability or an unwillingness to adhere to
a prescribed treatment regimen should be classified as nonadherent. Patients
should be considered unable or unwilling to adhere to prescribed treatment if
they do not report for directly observed therapy (DOT), refuse medication, or
show other evidence of not taking medications as prescribed (e.g., incorrect pill
counts or urine test showing no evidence of drug metabolites).
• Any health-care professional who is aware of a nonadherent TB patient should
contact the appropriate health official for necessary interventions. The health of-
ficial or a designated representative should meet with the patient to determine
why the patient is nonadherent. The patient may be unwilling to continue treat-
ment because the medication is causing side effects, because the patient may
have difficulty obtaining additional medication, or because the patient believes
the medication is no longer necessary. After determining why the patient is not
adhering to the treatment regimen, the health official should take appropriate
action, such as seeking court-ordered DOT.
Additional Reporting Recommendations
Reporting requirements should include any confirmed or suspected case of active
disease caused by M. tuberculosis  complex (i.e., M. tuberculosis, Mycobacterium
bovis, and/or Mycobacterium africanum ). State laws also should require drug suscep-
tibility tests for all patients for whom a specimen is available. The results should be
reported to local and/or state health departments. Reporting laws should require that
all reports and records of clinical or laboratory examination for the presence of TB be
kept in a confidential registry maintained by the state health agency.
When not prohibited by law, states also should require that information on the pa-
tient’s HIV infection status, when known, be included in TB case reports. From a
surveillance perspective, the inclusion of the patient’s HIV status is important to deter-
mine the impact of the HIV epidemic on TB cases; this information also is important
for case management and prioritizing contact investigations.
If HIV-related information is reported, states should ensure that this information is
protected under their specific HIV and acquired immunodeficiency syndrome (AIDS)
reporting laws and confidentiality laws. If a state does not have specific HIV or AIDS
confidentiality laws, it should ensure that HIV-related information is protected by ap-
plicable confidentiality laws for infectious diseases, communicable diseases, or
sexually transmitted diseases, or by other provisions for the protection of patient
medical records.
Health agencies that maintain both an HIV or AIDS registry and a TB registry should
permit the sharing of information between the registries to assist in case finding,
*States use different terms to describe patients who do not follow a prescribed treatment
regimen, including “noncompliant” and “noncooperative.” Throughout this document, the
term “nonadherent” is used to describe patients who do not follow a prescribed treatment
regimen.
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particularly when the HIV or AIDS registry has information regarding persons infected
with TB whose names have not been reported to the TB registry. Information about a
person’s HIV or AIDS status must be protected, even when it is reported to or shared
with another division within a health department.
Federally assisted substance-abuse treatment programs must report HIV- and TB-
related information for all patients in a manner consistent with federal regulations for
completing Confidentiality of Alcohol and Drug Abuse Patient Records*. Once the in-
formation from such treatment programs is reported to states, the information should
be protected in a manner consistent with the regulations.
Management of TB Cases
Provision of Treatment
Sixteen states specify that state-supported outpatient treatment must be made
available for persons with TB. Twenty-nine states recommend that TB patients volun-
tarily seek treatment before health officials seek state intervention.
Recommendations
• State laws should require that all TB patients receive immediate treatment ac-
cording to the most recent ATS/CDC and ACET treatment guidelines. These
guidelines include a) the examination of persons exposed to TB and persons sus-
pected of having active TB, b) the treatment of persons who have latent infection
or active TB, c) the duration of treatment, and d) the means for preventing TB
patients from infecting other people. States also should require that health-care
providers document patients’ adherence to prescribed therapy.
• States should require that health-care workers providing care to patients with
confirmed or suspected TB develop individualized, comprehensive treatment
plans for all TB patients. The plans should be developed in cooperation with the
patients and the appropriate health department and discussed with patients be-
fore they are discharged from treatment facilities. In addition, clinicians or other
designated persons in all correctional facilities should develop individualized,
comprehensive discharge plans for all TB-infected inmates who will be released
from the facility before they complete the prescribed course of therapy.
• Patients who do not adhere to self-administered therapy should receive DOT. In
addition, states should require the isolation of nonadherent, infectious patients
while they are receiving treatment. Persons who have drug-resistant TB should
be treated according to the most recent CDC treatment guidelines for drug-resis-
tant TB.
Penalty for Nonadherent Patients
Three states have provisions for imposing a fine on TB patients who do not adhere
to treatment. Four states specify certain behaviors that violate TB laws (e.g., breaking
quarantine or willfully transmitting disease), and 29 states provide that anyone
who violates the TB-control law may be quarantined. Two states have provisions for
*42 CFR 2.32.
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imposing an undefined penalty on nonadherent patients. In one state, violation of a
treatment plan or disruptive behavior within an institution justifies transfer to a correc-
tional facility where treatment will be provided.
Recommendation
• Penalties for nonadherent behavior should be levied only after the use of incen-
tives, enablers, voluntary or ordered DOT, and commitment for inpatient
management have failed to result in adherence to treatment.
Restrictions for Persons Infected with TB
Sixteen states require that persons infected or suspected of being infected with TB
be restricted from various activities. Typically, state laws require that persons infected
with TB be excluded from work until they are no longer infectious or until the absence
of TB has been medically demonstrated.
Recommendation
• Restricting the activities of a person with TB should be based on whether the
person has infectious TB and poses a risk to others. Restrictions should be termi-
nated when the person is no longer infectious.
Quarantine of Persons with TB
Forty-three states provide for the quarantine of TB patients within their own
homes. States define quarantine broadly and specifically. Statutes and regulations
also provide guidelines for the movement of patients outside of the home. Thirty-five
states specify that a quarantine should last until the person is no longer infectious.
However, the health officer with jurisdiction over the patient frequently determines the
exact length of quarantine.
Recommendation
• Quarantine, the traditional public health intervention of isolating persons who
are exposed to an infectious disease but are not yet infected, is no longer an
appropriate TB control measure. For patients with active TB who adhere to treat-
ment, temporary restriction to their primary residence may adequately protect
others from exposure. Such patients should be restricted to their residence until
they are noninfectious. Appropriate residence facilities should be designated for
the care of homeless persons infected with active TB.
Commitment of Persons with Infectious TB to Treatment Facilities
Forty-two states permit the commitment of TB patients to treatment facilities. How-
ever, the legal process for commitment and the duration of commitment vary in each
state. Twenty-four states require that persons committed for TB treatment remain hos-
pitalized until they no longer pose a health threat to others. Many state laws specify
that this condition be met when a patient becomes noninfectious. Seven states recom-
mend that a patient remain hospitalized until cured, and six states allow commitment
of persons with infectious TB for an unspecified period of time.
Some states allow patients who have been committed to petition the court for a
discharge and/or to appeal the decision. One state provides the patient the right to
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petition the court for discharge after 6 months, and nine states allow the patient to
appeal the commitment.
Recommendations
• Before committing TB patients for inpatient treatment, states should adopt step-
by-step interventions beginning with DOT and supplemented by incentives and
enablers. If a patient does not voluntarily adhere to DOT, the next step may be
DOT that is ordered by a public health official or a court. Only after the patient has
demonstrated an inability or an unwillingness to adhere to treatment regimens
should admission to a treatment facility be initiated. Commitment for inpatient
management should be viewed as the last measure for treatment of persons in-
fected with TB. However, when a person who has active, infectious TB refuses to
be isolated, emergency detention to isolate the person is appropriate.
• State laws should permit the involuntary isolation and detention of noninfectious
patients who, after being offered less restrictive alternatives, refuse to adhere to
a treatment regimen or to complete treatment. These persons are at risk for drug-
resistant TB, which can be transmitted to others.
• Commitment laws should specify a) where patients will be treated, b) the dura-
tion of commitment (e.g., until treatment is complete or until there is evidence
that the patient will adhere to the remainder of the treatment regimen), and c) the
reimbursement mechanism for the treatment.
• States should authorize the examination of persons suspected of having TB and
the emergency isolation and detention of persons who have infectious TB. Such
laws will permit local health officers to examine the contacts of persons with
infectious TB who are unwilling to seek evaluation and/or treatment. The laws
would permit local health officers to isolate and detain persons who have infec-
tious TB but who are unable or unwilling to receive treatment to prevent
transmission. The court review of emergency detention should expeditiously fol-
low the isolation of TB patients in a treatment facility. Voluntary treatment should
be pursued; however, appropriate commitment procedures should be initiated
immediately for patients who do not consent to isolation and treatment.
• As in commitment proceedings under state mental health laws, any law under
which a person may be examined, isolated, detained, committed, and/or treated
for TB must meet due process and equal protection requirements under state
and federal statutes and constitutions. Also, all patients who are subject to these
legal proceedings should be represented by legal counsel.
Commitment Orders. When determining whether the commitment of a person
with TB is necessary to protect the health of the public, local health officers should
determine whether that person presents a substantial risk for infecting others or de-
veloping drug-resistant disease. This determination should be based on an
individualized assessment of the situation, including consideration of the following
factors:
• Laboratory results or, in the absence of laboratory tests, clinical signs and symp-
toms of infectious TB;
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• Previous treatment for TB but failure to complete therapy for reasons unrelated
to access to treatment or medication;
• Adherence to prescribed therapy;
• Risk for infecting others depending on the patient’s housing and employment
situation;
• Laboratory tests or a history of nonadherence to anti-TB chemotherapy indicate
possible infection with drug-resistant M. tuberculosis .
When local health officers determine that commitment is necessary to protect the
health of the public, they should issue a commitment order in writing to local authori-
ties. The order should specify the name of the infected person, the period of time
during which the order is to remain effective, the facility to which the person will be
committed, and other terms or conditions necessary to protect the health of the pub-
lic. When an order is issued, a copy of the order should be given to the person named
in the order.
The commitment order should require that the person infected with TB be isolated
until he/she is determined to be noninfectious. This decision should be based on labo-
ratory results demonstrating that the person is smear negative and asymptomatic or
based on the local health officer’s determination that the person has completed a
course of therapy consistent with the most recent ATS/CDC treatment recommenda-
tions. The person also should be ordered to receive treatment in a hospital or other
appropriate facility until cured, unless the person’s voluntary completion of the or-
dered therapy can be ensured. If the person refuses to consent to the ordered
treatment, the health officer should have the authority to extend the commitment
order as necessary.
After receiving information that a commitment order has been violated, health offi-
cers should notify the appropriate official in the jurisdiction (e.g., a judge in the county
where the person resides) that a violation of the order has occurred. This notification
should be in writing and should explain the rationale for the hospitalization and the
facts about the violation.
Treatment Facilities
State statutes and regulations provide for TB treatment at public hospitals, sanito-
ria, and private hospitals that have entered into agreements for such treatment with
states. Thirty-three states provide or approve facilities for the treatment of TB patients.
Twenty-one states have adopted detailed guidelines for the testing, monitoring, and
care of the TB patient in treatment facilities.
Recommendations 
• To more efficiently treat TB patients, states should permit cities, counties, or
groups of counties to establish and maintain a variety of facilities for treating
persons infected with TB. Such facilities include shelters for the homeless, half-
way houses, and short- or long-term care facilities such as hospitals.
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• State health departments should develop standards based on the current
ATS/CDC recommendations and guidelines for local TB-control programs and fa-
cilities to use in treating TB and controlling its transmission.
Financing of Treatment
TB-control statutes in 46 states specify that the state will provide some reimburse-
ment for patient care. Payment provisions vary among these states. For example,
three states provide funding for the treatment of indigent patients only; three states
offer sliding-scale payments according to the patient’s financial status; and six states
require that if a patient has third-party insurance, the third-party payor must be the
first payor and the state the payor of last resort.
Recommendation
• States should specify how the treatment of TB patients will be paid. The patient’s
inability to pay for treatment should not be a barrier to receiving effective treat-
ment. Assuring treatment for all patients, regardless of their ability to pay, is
critical to preventing the transmission of TB in the community.
Investigation of TB Cases
Forty-nine states require the investigation of reported cases of TB. Forty-five states
specify that an investigation can be conducted when a health official receives a report
of a confirmed or suspected case of TB. Forty-one states authorize health departments
to investigate under certain circumstances, such as when a health officer suspects or
knows of a case of TB. Twenty-nine states specifically require contact investigations
for reported cases of TB.
Recommendations
• States should require local health officers to conduct immediate contact investi-
gations for all reported or suspected cases of pulmonary TB. During the
investigations, each health officer should be authorized to examine and order the
isolation of persons suspected of having or known to have infectious TB and to
detain persons known to be nonadherent to prescribed therapy.
• Health officers should be authorized to order a physical examination of persons
suspected of having TB. The examination order should be submitted in writing
and should specify the name of the person to be examined, the time and the
place where the examination is to be conducted, the medical basis for the exami-
nation order, and any other terms or conditions necessary to protect the health of
the public. In addition, health officers should have the authority to review all pa-
tient records of both public and private institutions, clinics, and practices where
TB patients are treated.
Screening for TB
Forty-four states require that certain populations be screened for TB. Screening is
frequently required for school employees (20 states), employees of medical facilities
(18 states), and day care employees (11 states). TB testing is typically required before
the start of employment. Eleven states also require that schoolchildren be screened
for TB.
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Recommendation
• To eliminate TB, states must interrupt the transmission of tubercle bacilli by pre-
venting, identifying, and treating TB-infected persons. TB screening may include
screening for latent TB infection, active disease, or both. Screening requirements
should be based on an analysis of epidemiologic data (including disease fre-
quency and the demographic and geographic distribution of disease in the
community) and morbidity trends, and ALA/ATS/CDC/ACET recommendations
and guidelines for screening populations, institutions (including health-care and
correctional facilities), and personnel.
TB-Control Officers
State laws and regulations generally do not designate a TB-control officer to super-
vise the state TB-control program. However, every state currently has a designated
person responsible for their state TB-control program.
Recommendation
• Each state should designate a TB-control officer to supervise TB-control pro-
grams. These officers should have sufficient authority to address the current
problems in TB control.
Responsibilities. TB-control officers should be responsible for all statewide TB-
 control activities. They should cooperate with local health departments and other
appropriate organizations to conduct or supervise clinics that diagnose, treat, and
control TB throughout the state. The officers should maintain a registry of all cases,
suspected cases, and contacts.
Authority. To conduct TB-control measures, TB-control officers must have the
authority to examine all records, reports, and other data pertaining to confirmed and
suspected TB patients. The records of the TB-control officer must be confidential and
the identity of patients must not be disclosed, except where disclosure is necessary as
part of official TB-control activities.
In addition, the officers should have the authority to examine or order the examina-
tion of any person known to have or suspected of having TB. The officers also should
be authorized to perform or order any laboratory tests or radiographic examinations
necessary to diagnose and treat any patient who has TB.
TB-control officers should have the authority to issue emergency examination, iso-
lation, and detention orders for persons suspected of having active TB, and issue
commitment orders for persons who have active TB or who are nonadherent to the
prescribed therapy. Such decisions should be based on guidelines issued by the state
health department. TB-control officers also should be directed to cooperate with state
and federal agencies in the prevention and control of TB.
CONCLUSION
A survey of state TB-control laws and regulations indicates that states differ in their
approach to the control of TB. This report provides recommendations from the ACET
that can be used in revising state TB-control laws. The purpose of providing these
recommendations is to increase uniformity among TB-control programs. These
Vol. 42 / No. RR-15 MMWR 11
recommendations also are designed to encourage states to adopt flexible TB-control
laws and regulations that will accommodate new TB-control recommendations and
guidelines as they are published.
The goal of TB-control programs is to eliminate TB by appropriately treating per-
sons infected with TB, to safeguard the confidentiality and civil liberties of persons
who have TB, and to protect them from unlawful discrimination because of their dis-
ease (see box).
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Tuberculosis reporting requirements: persons required by law to report confirmed and suspected cases, by state, 1993
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Tuberculosis reporting requirements: time frame for reporting, penalty for failure to report, and duty to report nonadherent
patients, by state, 1993
State
Time frame for reporting confirmed or suspected cases
24
hours
48
hours
72
hours
1
 week At time of diagnosis Unspecified
Penalty for failure
to report
Duty to report
nonadherent
patients
AL X X
AK X
AZ X
AR X
CA X
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CT X X X
DE X
FL X X
GA
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ID X
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KY X X
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Tuberculosis reporting requirements: time frame for reporting, penalty for failure to report, and duty to report nonadherent
patients, by state, 1993
State
Time frame for reporting confirmed or suspected cases
24
hours
48
hours
72
hours
1
 week At time of diagnosis Unspecified
Penalty for failure
to report
Duty to report
nonadherent
patients
OK X
OR X
PA X
RI X X
SC X
SD X
TN X
TX X
UT
VT X
VA
WA X X
WV X X
WI X X X
WY X X
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Populations subject to tuberculosis screening, by state, 1993
State
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children
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Park
 employees
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 employees
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facility
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 beauticians
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facility
 employees
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home
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Populations subject to tuberculosis screening, by state, 1993
State
Medical
facility
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employees
Foster home
residents
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children
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bus
 drivers
Incarcerated
persons Food handlers
Park
 employees
Child or
day care
 employees
Long-term
care
facility
residents
Barbers/
 beauticians
Correctional
facility
 employees
Nursing
home
employees
NH
OK X X
OR X X X
PA X
RI
SC X X
SD
TN
TX X X
UT X X X X X
VT
VA
WA X X X X X
WV X X
WI X X X X
WY
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Tuberculosis control programs, by state, 1993
Initiation of investigation Procedures for treatment and control
State
Upon
receipt of
report
When health
officer has
knowledge
or suspicion
Tracing of
contacts
Voluntary
treatment
Outpatient
treatment
Home
quarantine Commitment
Commitment
until no longer
a threat
Commitment
until cured
Commitment
for unspecified
time
Consideration of
carrier’s
religious beliefs
Penalty for
nonadherent
patients
AL X X X X X X X X X
AK X X X
AZ X X X X X X
AR X X X X X X
CA X X X X X X X X X
CO X X X X X X X X
CT X X X X X X
DE X X X X X X
FL X X X X X X X X X
GA X X X X X X
HI X X X X X X X
ID X X X X X
IL X X X X X X
IN X X X X X X
IA X X X X X
KS X X X X X X X X
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Tuberculosis control programs, by state, 1993
Initiation of investigation Procedures for treatment and control
State
Upon
receipt of
report
When health
officer has
knowledge
or suspicion
Tracing of
contacts
Voluntary
treatment
Outpatient
treatment
Home
quarantine Commitment
Commitment
until no longer
a threat
Commitment
until cured
Commitment
for unspecified
time
Consideration of
carrier’s
religious beliefs
Penalty for
nonadherent
patients
OK X X X X X 
OR X X X X X
PA X X X X X X 
RI
SC X X X X X X X
SD X X X X X X 
TN X X X X X X X X
TX X X X X X X
UT X X X X X X
VT X X X X X X 
VA X X X X X X
WA X X X X X X X X
WV X X X X X
WI X X X X X X X X
WY X X X
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Provisions of treatment for persons with tuberculosis, by state, 1993 
Treatment facilities
Financing of treatment
State
State
provides/ approves
State provides
guidelines for
patient care Public Private
Health department
access to medical
records
Confidentiality
provisions
AL X X X X
AK X X X
AZ X X X
AR X X
CA X X X X
CO X X X X
CT X X X
DE X X X
FL X X X X X
GA X X
HI X X X X
ID X X X X
IL X X X X X
IN X X X
IA X X X
KS X X X X X
KY
LA X X
ME X X X X
MD X X X
MA X X X X
MI X X X X
MN X X X X
MS X X X X
MO X X X X
MT X X X
NE X X X X X
NV X X X X X
NJ
NH X X X X X X
NM X
NY X X X X X
NC X X X X
ND X X X X
OH X X X X X X
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Provisions of treatment for persons with tuberculosis, by state, 1993 
Treatment facilities
Financing of treatment
State
State
provides/ approves
State provides
guidelines for
patient care Public Private
Health department
access to medical
records
Confidentiality
provisions
OK X X
OR X X
PA
RI X X
SC X X X X X X
SD X X X X 
TN X X X X X X
TX X X X X X
UT X X
VT X X X
VA X X X X X
WA X X X X X 
WV X X X
WI X X X X X
WY X X X X
20
M
M
W
R
N
ovem
ber 12, 1993
Tuberculosis reporting requirements: patient and case information that must be reported to state health department, by
state, 1993
Patient information Case information
State  Name Address
Telephone
number
 Date of
  birth  Sex
Race/
ethnicity
Place of
work/school
 Treating
 physician
 Physician’s 
 address
Date of
 onset
Basis of
diagnosis
Contact
information
AL X X X X X X X
AK X X X X X X
AZ X X X X X X X X X X X
AR X X X X X X X X
CA X X X X X X X X
CO X X X X X X X
CT X X X X X X
DE X X X X X
DC X X X X X X X X X
FL X X X X X X X X
GA
HI X X X X X X
ID X X X X X X X
IL X X X X X X X
IN X X X X X X X X X
IA
KS
KY X X X X X X X X
LA X X X X X X
ME X X X X X X X X
MD
MA
MI X X X X X X X X X X
MN X X X X X X X X X X
MS X X X X X X X
MO X X X X X X
MT X X X X X
NE
NV
NJ X X X X X X X
NH X X X X X X X X
NM
NY X X X X X X
NC
ND X X X X X X
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Tuberculosis reporting requirements: patient and case information that must be reported to state health department, by
state, 1993
Patient information Case information
State  Name Address
Telephone
number
 Date of
  birth  Sex
Race/
ethnicity
Place of
work/school
 Treating
 physician
 Physician’s 
 address
Date of
 onset
Basis of
diagnosis
Contact
information
OH
OK X X X X X X X X X
OR X X X X X X X
PA X X X X X
RI X X X X X X
SC X X X X X
SD
TN X X X X X
TX X X X X X X
UT X X X X X
VT X X X
VA X X X X X X X
WA X X X X X X
WV X X X
WI X X X X X X X
WY
Persons restricted from activities and/or employment if infected with tuberculosis, by
state, 1993
State
Food
handlers
School-
children
School
employees
Care
providers*
Household
contacts
AL
AK
AZ
AR X X X
CA
CO
CT
DE
FL X
GA
HI X X X
ID X X X X X
IL X
IN
IA
KS X X
KY X
LA
ME X X
MD X
MA
MI X
MN
MS X X
MO X X
MT X X X
NE
NV
NJ X
NH
NM X
NY
NC
ND X X X X
OH
OK X
OR X X X
PA X
RI
SC X X X
SD
TN X X X
TX
UT
VT
VA
WA
WV X
WI X X X
WY
*Includes day care providers, nursing-home employees, and home health-care workers.
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